c-Src-mediated activation of Erk1/2 is a reaction of epithelial cells to carbon nanoparticle treatment and may be a target for a molecular preventive strategy.
about
Chemical basis of interactions between engineered nanoparticles and biological systemsCellular targets and mechanisms in the cytotoxic action of non-biodegradable engineered nanoparticlesNoninterventional open-label trial investigating the efficacy and safety of ectoine containing nasal spray in comparison with beclomethasone nasal spray in patients with allergic rhinitis.Carbon nanoparticles induce ceramide- and lipid raft-dependent signalling in lung epithelial cells: a target for a preventive strategy against environmentally-induced lung inflammationEfficacy and tolerability of an ectoine mouth and throat spray compared with those of saline lozenges in the treatment of acute pharyngitis and/or laryngitis: a prospective, controlled, observational clinical trialReduction of neutrophilic lung inflammation by inhalation of the compatible solute ectoine: a randomized trial with elderly individuals.The compatible solute ectoine reduces the exacerbating effect of environmental model particles on the immune response of the airways.The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles.Cellular Response to Titanium Dioxide Nanoparticles in Intestinal Epithelial Caco-2 Cells is Dependent on Endocytosis-Associated Structures and Mediated by EGFRPotential applications of stress solutes from extremophiles in protein folding diseases and healthcare.A correlative approach at characterizing nanoparticle mobility and interactions after cellular uptake.Dependence of Nanoparticle Toxicity on Their Physical and Chemical Properties.Non-Canonical Activation of the Epidermal Growth Factor Receptor by Carbon Nanoparticles.
P2860
Q27021154-6CFD5F82-47AC-4BC6-8900-081772681F7FQ28390739-0EC66280-0706-45FA-823F-5C97488B09F1Q33757382-76D53612-6FBF-434C-BA39-DBA22D0E6FA6Q36536111-C395DBB9-311C-43E0-A0DA-F32870C6340AQ37153374-68DF4923-ACC4-4033-BAF8-6CCB7B63BB43Q37361474-AE365FD3-920B-4EDB-B55B-76EEB8F3B84CQ37733408-9E2FAFED-1096-4154-9202-68F231E6DA07Q38059207-0C9814C3-7A6A-40CE-8947-D1768512F072Q38708542-CD510F4D-C6DF-44E7-84C7-5F9828BCDAB4Q38806392-448A8457-2072-4DE3-8F2A-7A458D90C0D5Q39460323-7C3D05CC-FB08-468B-B393-7D1BDD9F82F1Q49370039-E6A3F74E-AD34-44E0-A8D4-AF734B107601Q54114534-359D7746-29CF-4F8E-B4BA-9231AB39B582
P2860
c-Src-mediated activation of Erk1/2 is a reaction of epithelial cells to carbon nanoparticle treatment and may be a target for a molecular preventive strategy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
c-Src-mediated activation of E ...... molecular preventive strategy.
@en
c-Src-mediated activation of E ...... molecular preventive strategy.
@nl
type
label
c-Src-mediated activation of E ...... molecular preventive strategy.
@en
c-Src-mediated activation of E ...... molecular preventive strategy.
@nl
prefLabel
c-Src-mediated activation of E ...... molecular preventive strategy.
@en
c-Src-mediated activation of E ...... molecular preventive strategy.
@nl
P2093
P2860
P356
P1433
P1476
c-Src-mediated activation of E ...... molecular preventive strategy.
@en
P2093
Daniel Stöckmann
Henrike Peuschel
Klaus Unfried
Matthias Kroker
Nicole Büchner
Ragnhild Wirth
Ulrich Sydlik
Winfried Brock
P2860
P304
P356
10.1515/BC.2010.131
P577
2010-11-01T00:00:00Z